ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351909. A total of 5 filers reported holding ALEXION PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,906,000 | +38.9% | 18,600 | 0.0% | 0.00% | – |
| Q3 2020 | $2,092,000 | -86.6% | 18,600 | -86.6% | 0.00% | -100.0% |
| Q2 2020 | $15,556,000 | +136.7% | 138,600 | +89.3% | 0.00% | +50.0% |
| Q1 2020 | $6,573,000 | -53.7% | 73,200 | -44.2% | 0.00% | -33.3% |
| Q4 2019 | $14,189,000 | +10.9% | 131,200 | +0.5% | 0.00% | 0.0% |
| Q3 2019 | $12,791,000 | -11.7% | 130,600 | +13.7% | 0.00% | 0.0% |
| Q2 2019 | $14,490,000 | +42.7% | 114,900 | +53.0% | 0.00% | +50.0% |
| Q1 2019 | $10,152,000 | -58.9% | 75,100 | -70.4% | 0.00% | -66.7% |
| Q4 2018 | $24,681,000 | +97.5% | 253,500 | +182.0% | 0.01% | +200.0% |
| Q3 2018 | $12,497,000 | +14.4% | 89,900 | +2.2% | 0.00% | 0.0% |
| Q2 2018 | $10,925,000 | -56.3% | 88,000 | -60.8% | 0.00% | -60.0% |
| Q1 2018 | $25,023,000 | +260.8% | 224,500 | +287.1% | 0.01% | +400.0% |
| Q4 2017 | $6,936,000 | +4.5% | 58,000 | +20.8% | 0.00% | 0.0% |
| Q3 2017 | $6,640,000 | +172.9% | 48,000 | +140.0% | 0.00% | 0.0% |
| Q2 2017 | $2,433,000 | -78.7% | 20,000 | -78.8% | 0.00% | -66.7% |
| Q1 2017 | $11,421,000 | – | 94,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|